Outcomes of Covid 19 patients—Are Hispanics at greater risk?

Disparities in outcomes exist in outcomes of coronavirus disease‐19 (COVID‐19). Little is known about other ethnic minorities in United States. We included all COVID‐19 positive adult patients (≥18 years) hospitalized between March 1, 2020 and February 5th 2021. We compared in hospital mortality, use of intensive care unit services and inflammatory markers between non‐Hispanic whites with non‐White/Black Hispanic. Multivariable Cox proportional Hazard models were used to adjust for differences between the two groups. There were 4059 hospital admissions with COVID‐19 in the study period. Of the 3288 White, 789 (24%) required intensive care unit (ICU) admission in comparison to 187 (24.3%) of the 770 Hispanics. Unadjusted mortality was higher in Whites than Hispanics (17.1% vs. 10.7%; p < 0.001). After adjusting for confounding variables, in‐hospital mortality was not statistically different for Whites in comparison to Hispanics (hazard ratio [HR]: 0.96, 95% confidence interval [CI]: 0.76–1.21, p = 0.73). The adjusted rates of ICU transfers were significantly higher in Hispanics (HR: 1.34, 95% CI: 1.11–1.61, p = 0.002). Hispanics had significantly higher C‐reactive protein, lactate dehydrogenase, and fibrinogen when compared to Whites. Hispanics as compared to Whites with COVID‐19 require higher rates of ICU admission but have a similar mortality. Hispanics as compared to Whites with COVID‐19 require higher rates of ICU admission but have a similar mortality. [ABSTRACT FROM AUTHOR]